āĻšā§āĻŽ22Z âĸ FRA
add
Zealand Pharma A/S
ā§Ē⧝.ā§ā§âŦ
ā§ āĻā§āϞ, ⧧⧍:ā§Ģā§Ž:ā§Ģā§Ŧ PM GMT +⧍ · EUR · FRA · āĻĄāĻŋāϏāĻā§āϞā§āĻŽāĻžāϰ
āĻāĻžāϞ āĻļā§āώ āϝ⧠āĻĻāĻžāĻŽā§ āĻāĻŋāϞ
ā§Ēā§Ž.ā§Ē⧝âŦ
āϏāĻžāϰāĻž āĻĻāĻŋāύā§āϰ āĻā§āϰā§āĻĄāĻŋāĻā§ā§ āϏā§āĻāĻā§āϰ āĻĻāĻžāĻŽā§āϰ āĻāĻ āĻž āύāĻžāĻŽāĻžāϰ āϰā§āĻā§āĻ
ā§Ē⧝.ā§ā§âŦ - ā§Ē⧝.ā§ā§âŦ
āϏāĻžāϰāĻž āĻŦāĻāϰā§āϰ āϰā§āĻā§āĻ
ā§Ēā§.ā§Ļā§ĢâŦ - ā§§ā§Šā§Ļ.ā§Ēā§ĻâŦ
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
⧍ā§Ŧ.ā§ā§ĢāĻļāĻ¤Â āĻā§ DKK
āĻāĻĄāĻŧ āĻāϞāĻŋāĻāĻŽ
⧧⧍⧝.ā§Ļā§Ļ
P/E āĻ
āύā§āĻĒāĻžāϤ
-
āϞāĻā§āϝāĻžāĻāĻļ āĻĒā§āϰāĻĻāĻžāύ
-
āĻĒā§āϰāĻžāĻāĻŽāĻžāϰāĻŋ āĻāĻā§āϏāĻā§āĻā§āĻ
CPH
āĻŦāĻžāĻāĻžāϰ āϏāĻāĻŦāĻžāĻĻ
āĻĢāĻžāĻāύāĻžāύā§āϏāĻŋā§āĻžāϞ āĻĒāĻžāϰāĻĢāϰā§āĻŽā§āϝāĻžāύā§āϏ
āĻā§ā§āϰ āϏā§āĻā§āĻāĻŽā§āύā§āĻ
āĻāĻĒāĻžāϰā§āĻāύ
āύā§āĻ āĻāύāĻāĻžāĻŽ
(DKK) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻāĻĒāĻžāϰā§āĻāύ | ā§Žā§Ļ.ā§¯ā§¨Â āϞāĻž | -ā§Ēā§Ŧ.ā§Šā§% |
āĻŦā§āϝāĻŦāϏāĻž āĻāĻžāϞāĻžāύā§āϰ āĻāϰāĻ | ā§Ēā§§.ā§Ēā§Â āĻā§ | ā§Ģā§Ģ.ā§ā§¨% |
āύā§āĻ āĻāύāĻāĻžāĻŽ | -ā§Šā§Š.ā§Ģā§ŠÂ āĻā§ | -ā§Ēā§Ŧ.ā§Ŧā§Ŧ% |
āύā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ āĻŽāĻžāϰā§āĻāĻŋāύ | -ā§Ē.ā§§ā§Ē āĻšāĻž | -ā§§ā§ā§Š.ā§Ēā§Ž% |
āĻļā§ā§āĻžāϰ āĻĒā§āϰāϤāĻŋ āĻāĻĒāĻžāϰā§āĻāύ | -ā§Ē.ā§ā§Ģ | -ā§¨ā§Ž.ā§Ļā§Š% |
EBITDA | -ā§Ēā§Ļ.ā§§ā§§Â āĻā§ | -ā§Ŧā§Ļ.ā§¯ā§Š% |
āĻĒā§āϰāϝā§āĻā§āϝ āĻā§āϝāĻžāĻā§āϏā§āϰ āĻšāĻžāϰ | ā§Ļ.ā§Ēā§§% | â |
āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļāĻŋāĻ
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
(DKK) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻā§āϝāĻžāĻļ āĻ āĻāĻŽ āϏāĻŽā§ā§āϰ āĻŦāĻŋāύāĻŋā§ā§āĻ | ā§Žā§Ģā§Ē.ā§Ēā§Ģ āĻā§ | ā§§ā§Ŧā§Š.ā§Ē⧍% |
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | ⧝⧧⧍.ā§¨ā§¨Â āĻā§ | ā§§ā§Ģā§Ē.ā§Šā§Š% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§Žā§§.ā§Šā§Â āĻā§ | ā§Ž.ā§Ŧā§% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§Žā§Šā§Ļ.ā§Žā§Ģ āĻā§ | â |
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ | ā§.ā§Ļā§Â āĻā§ | â |
āĻĒā§āϰāĻžāĻāϏ āĻā§ āĻŦā§āĻ āϰā§āĻļāĻŋāĻ | ā§Ļ.ā§Ēā§§ | â |
āϏāĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | -ā§§ā§Ļ.ā§¯ā§Š% | â |
āĻŽā§āϞāϧāύ āĻĨā§āĻā§ āĻā§ | -ā§§ā§§.ā§Ē⧝% | â |
āĻā§āϝāĻžāĻļ āĻĢā§āϞā§
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ
(DKK) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āύā§āĻ āĻāύāĻāĻžāĻŽ | -ā§Šā§Š.ā§Ģā§ŠÂ āĻā§ | -ā§Ēā§Ŧ.ā§Ŧā§Ŧ% |
āĻ
āĻĒāĻžāϰā§āĻļāύ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āϝāĻžāĻļ | -ā§Ģā§Ļ.ā§Ļā§ŽÂ āĻā§ | -ā§§ā§¨ā§Š.ā§Žā§¯% |
āĻŦāĻŋāύāĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | ā§Ģā§Ģ.ā§Ēā§Ŧ āĻā§ | ā§§ā§Ēā§Ļ.ā§¨ā§Š% |
āĻĢāĻžāĻāύā§āϝāĻžāύā§āϏāĻŋāĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§.ā§¯ā§§Â āϞāĻž | -ā§§ā§Ļā§Ļ.ā§Ļā§Ē% |
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ | ā§Ģ.ā§Ļā§§Â āĻā§ | -ā§ā§.ā§Ģā§Š% |
āĻĢā§āϰāĻŋ āĻā§āϝāĻžāĻļ āĻĢā§āϞ⧠| -ā§Šā§¯.ā§Žā§§Â āĻā§ | -ā§§ā§Ŧ⧝.ā§ā§Ž% |
āϏāĻŽā§āĻĒāϰā§āĻā§
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ā§āĻā§
ā§§ āĻāĻĒā§āϰāĻŋ, ⧧⧝⧝ā§
āĻā§ā§āĻŦāϏāĻžāĻāĻ
āĻāϰā§āĻŽāĻāĻžāϰā§
ā§Šā§Žā§Ģ